Skip to main content
SpringerLink
Log in

Loss of CD5-positive T-cells following anti-thymocyte globulin treatment

  • Images
  • Published:
Journal of Hematopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Storek J, Mohty M, Boelens JJ (2015) Rabbit anti-T cell globulin in allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 21(6):959–970. https://doi.org/10.1016/j.bbmt.2014.11.676

    Article  CAS  PubMed  Google Scholar 

  2. Mohty M (2007) Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 21(7):1387–1394. https://doi.org/10.1038/sj.leu.2404683

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was not supported by any funding.

Author information

Authors and Affiliations

  1. Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA

    Melissa B. Herring & Sebastian Fernandez-Pol

Authors
  1. Melissa B. Herring
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sebastian Fernandez-Pol
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Melissa B. Herring.

Ethics declarations

Declarations

The authors have no relevant financial or non-financial interests to disclose. The authors have no competing interests to declare that are relevant to the content of this article. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. The authors have no financial or proprietary interests in any material discussed in this article.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

This work is covered by protocol approved by the Stanford University Institutional Review Board that does not require informed consent due to the retrospective nature of the work and the lack of data that could potentially identify the patient.

Consent for publication

The protocol that covers this case report does not require consent and no protected health information is present in this manuscript.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Herring, M.B., Fernandez-Pol, S. Loss of CD5-positive T-cells following anti-thymocyte globulin treatment. J Hematopathol (2024). https://doi.org/10.1007/s12308-024-00581-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12308-024-00581-y

Keywords

Search

Navigation